New research from scientists at the University of Nottingham, supported by Breast Cancer Now, shows how a group of proteins could tell us how different types of breast cancer might progress in the future.
The proteins are known as calpains and calpastatin, and they help cancer cells survive and spread around the body. The research undertaken by Professor Steven Martin at the University’s Translational and Radiation Biology Research group, studied large primary breast tumours with high levels of calpain. When these patients were given chemotherapybefore surgery they were more likely to survive than patients with low calpain levels.
See press release.
University of Nottingham Biodiscovery Institute (Room C214) University Park Science Road Nottingham, NG7 2RD
email: nbcrc@nottingham.ac.uk